有过敏反应报告的患者的COVID-19疫苗接种：最新证据与建议方法 - Suppr

COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach.

作者信息

Banerji Aleena, Wolfson Anna R, Wickner Paige G, Cogan Amelia S, McMahon Aubree E, Saff Rebecca, Robinson Lacey B, Phillips Elizabeth, Blumenthal Kimberly G

机构信息

Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.

出版信息

J Allergy Clin Immunol Pract. 2021 Jun;9(6):2135-2138. doi: 10.1016/j.jaip.2021.03.053. Epub 2021 Apr 15.

DOI:10.1016/j.jaip.2021.03.053

PMID:33866033

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8049186/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2717/8049186/279cbb6db4e9/gr1_lrg.jpg

相似文献

COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach.有过敏反应报告的患者的COVID-19疫苗接种：最新证据与建议方法

J Allergy Clin Immunol Pract. 2021 Jun;9(6):2135-2138. doi: 10.1016/j.jaip.2021.03.053. Epub 2021 Apr 15.

Anaphylaxis is a rare reaction in COVID-19 vaccination.在 COVID-19 疫苗接种中，过敏反应较为罕见。

J Biol Regul Homeost Agents. 2021 May-Jun;35(3):839-842. doi: 10.23812/BELLOMO_EDIT_3_21.

Allergic Reactions After COVID-19 Vaccination-Putting Risk Into Perspective.新冠疫苗接种后的过敏反应——正确看待风险

JAMA Netw Open. 2021 Aug 2;4(8):e2122326. doi: 10.1001/jamanetworkopen.2021.22326.

Management of patients at risk of anaphylaxis after COVID 19 vaccination.COVID-19 疫苗接种后发生过敏反应风险患者的管理。

J Biol Regul Homeost Agents. 2021 May-Jun;35(3):843-846. doi: 10.23812/21-20-E.

Hypersensitivity Reactions to Vaccines: Current Evidence and Standards for SARS-CoV-2 Vaccines.疫苗过敏反应：SARS-CoV-2 疫苗的现有证据和标准。

Acta Med Port. 2021 Jun 30;34(7-8):541-547. doi: 10.20344/amp.16096. Epub 2021 May 21.

[Anaphylaxis caused by vaccines].[疫苗引起的过敏反应]

Rev Alerg Mex. 2022;69 Suppl 1:s1-s14. doi: 10.29262/ram.v69iSupl1.989.

[Not Available].[无可用内容]

Laryngorhinootologie. 2021 May;100(5):344-354. doi: 10.1055/a-1397-0754. Epub 2021 Mar 8.

Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts.过敏性皮肤病患者接种新型冠状病毒肺炎疫苗后发生严重过敏反应的风险——实用建议。欧洲皮肤科和性病学会与外部专家的立场声明

J Eur Acad Dermatol Venereol. 2021 Jun;35(6):e362-e365. doi: 10.1111/jdv.17237. Epub 2021 Apr 3.

[MANAGEMENT, DIAGNOSIS, AND TREATMENT OF SEVERE ALLERGIC REACTIONS INCLUDING ANAPHYLAXIS TO COVID-19 VACCINE].[严重过敏反应的管理、诊断和治疗，包括对新冠疫苗的过敏反应]

Arerugi. 2021;70(3):215-223. doi: 10.15036/arerugi.70.215.

A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies.一种与新冠疫苗接种策略相关的住院、死亡和经济结果的成本效益评估：普遍接种与基于过敏风险分层接种的比较。

J Allergy Clin Immunol Pract. 2021 Jul;9(7):2658-2668.e3. doi: 10.1016/j.jaip.2021.02.054. Epub 2021 Mar 9.

引用本文的文献

Fear, facts, and the future: An update on coronavirus disease 2019 vaccine-induced anaphylaxis and vaccine hesitancy among those living with allergy.恐惧、事实与未来：2019冠状病毒病疫苗诱导的过敏反应及过敏患者中疫苗犹豫情况的最新进展

J Allergy Clin Immunol Glob. 2025 Jun 23;4(4):100522. doi: 10.1016/j.jacig.2025.100522. eCollection 2025 Nov.

Challenges in diagnosing polyethylene glycol and polysorbate 80 allergies: implications for allergic reactions in COVID-19 mRNA vaccination program: experience from Qatar.聚乙二醇和聚山梨醇酯80过敏诊断中的挑战：对COVID-19 mRNA疫苗接种计划中过敏反应的影响：来自卡塔尔的经验

Front Allergy. 2025 Jan 7;5:1502285. doi: 10.3389/falgy.2024.1502285. eCollection 2024.

Algorithms in allergy: Management of allergic reactions to COVID-19 vaccines.过敏症中的算法：新冠疫苗过敏反应的管理

Allergy. 2025 Feb;80(2):638-640. doi: 10.1111/all.16358. Epub 2024 Oct 30.

Incidence and Outcomes of COVID-19 Vaccine Hypersensitivity Reactions and Success of COVID-19 Vaccine Provocation Tests Post Previous COVID-19 Vaccine Hypersensitivity.新型冠状病毒肺炎疫苗超敏反应的发生率、结局以及既往新型冠状病毒肺炎疫苗超敏反应后新型冠状病毒肺炎疫苗激发试验的成功率

Medicines (Basel). 2024 May 27;11(6):12. doi: 10.3390/medicines11060012.

Vaccine confidence among those living with allergy during the COVID pandemic (ACCORD): A scoping review.新冠疫情期间过敏症患者的疫苗信心（ACCORD）：一项范围综述

J Allergy Clin Immunol Glob. 2023 May;2(2):100079. doi: 10.1016/j.jacig.2023.100079. Epub 2023 Feb 8.

Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees.抗SARS-CoV-2疫苗接种者中严重过敏与焦虑之间的相互作用。

Vaccines (Basel). 2022 Nov 30;10(12):2047. doi: 10.3390/vaccines10122047.

COVID-19 vaccine provocation test outcome in high-risk allergic patients: A retrospective study from a tertiary hospital in Indonesia.COVID-19疫苗激发试验在高危过敏患者中的结果：来自印度尼西亚一家三级医院的回顾性研究。

World Allergy Organ J. 2023 Jan;16(1):100734. doi: 10.1016/j.waojou.2022.100734. Epub 2022 Dec 13.

Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis.COVID-19 疫苗过敏反应疫苗和疫苗赋形剂检测的诊断准确性：系统评价和荟萃分析。

Allergy. 2023 Jan;78(1):71-83. doi: 10.1111/all.15571. Epub 2022 Nov 23.

Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics.儿童变态反应性疾病和免疫缺陷，2022 年从 COVID-19 大流行中吸取的教训：EAACI 儿科分会的声明。

Pediatr Allergy Immunol. 2022 Oct;33(10):e13851. doi: 10.1111/pai.13851.

Management of patients with allergic diseases in the era of COVID-19.2019冠状病毒病时代过敏性疾病患者的管理

Clin Exp Pediatr. 2022 Nov;65(11):529-535. doi: 10.3345/cep.2022.00759. Epub 2022 Sep 23.

本文引用的文献

Acute Allergic Reactions to mRNA COVID-19 Vaccines.mRNA COVID-19 疫苗的急性过敏反应。

JAMA. 2021 Apr 20;325(15):1562-1565. doi: 10.1001/jama.2021.3976.

First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021.2020 年 12 月 14 日至 2021 年 1 月 13 日，COVID-19 疫苗安全监测第一个月-美国。

MMWR Morb Mortal Wkly Rep. 2021 Feb 26;70(8):283-288. doi: 10.15585/mmwr.mm7008e3.

Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.2020年12月14日至2021年1月18日美国接种mRNA新冠疫苗后发生过敏反应的报告

JAMA. 2021 Mar 16;325(11):1101-1102. doi: 10.1001/jama.2021.1967.

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.美国 2020 年 12 月 14 日至 23 日：在接种第一剂辉瑞-BioNTech COVID-19 疫苗后出现过敏反应（包括过敏反应）。

MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):46-51. doi: 10.15585/mmwr.mm7002e1.

mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach.mRNA 疫苗预防 COVID-19 疾病和报告的过敏反应：当前证据和建议方法。

J Allergy Clin Immunol Pract. 2021 Apr;9(4):1423-1437. doi: 10.1016/j.jaip.2020.12.047. Epub 2020 Dec 31.

Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized.对聚乙二醇和聚山梨酯的即刻过敏反应：比我们认识到的更为常见。

J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1533-1540.e8. doi: 10.1016/j.jaip.2018.12.003. Epub 2018 Dec 14.

Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80.因聚山梨醇酯80导致的人乳头瘤病毒疫苗超敏反应。

BMJ Case Rep. 2012 May 8;2012:bcr0220125797. doi: 10.1136/bcr.02.2012.5797.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献